quarterly must be out soon, page-2

My base prediction is $1.8 million EBITDA, for TOX to have an EBITDA lower than this they would have to have 0% organic growth. I'm hoping for $1.9 million EBITDA +. Obviously anything above $2 million would be huge, because of their forecasted $8 million for the year, everyone would see that they will easily exceed this forecast. Congratulations to all the patient holders on this one who didn't worry about the drifting share price over the last 6 months (pre-consolidation and takeover rumours).